Last updated 9 months ago
A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis
123 patients around the world
Available in Colombia, Chile, Mexico, Argentina, United States
Boehringer Ingelheim
12Research sites
123Patients around the world
This study is for people with
Psoriasis
Generalized pustular psoriasis
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Sites
Sala de Primeros Auxilios Alberto Mignaburu - Berazategui, Prov Buenos Aires
Recruiting
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Recruiting
Hospital Italiano de Buenos Aires - CABA, Buenos Aires
Recruiting
CEDIC Centro de Investigación Clínica - CABA, Buenos Aires
Recruiting
Centro Médico - Buenos Aires Skin S.A. - CABA, Buenos Aires
Recruiting
Hospital Universitário Gaffrée e Guinle - HUGG/UNIRIO
Recruiting
Clínica Dermacross S.A. - Vitacura - Santiago
Recruiting
Corporación para Estudio en Salud “CES”–Clínica CES - Medellín
Recruiting
CIREEM SAS (Centro de Investigación en Reumatología y Especialidades Médicas) - Bogotá
Recruiting
Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
Recruiting
StudyEffisayil™ 2
SponsorBoehringer Ingelheim
Study typeInterventional
Conditions
Generalized pustular psoriasis
Requirements
To 75 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT04399837
